CTIS.eu › Cities › Denmark › Herlev
Herlev
Denmark
293 total trials
133 recruiting
2024-513727-16-00
4
2022-12-05
Advanced Angiosarcoma and Undifferentiated Pleomorphic Sarcoma
2023-505163-37-00
3
2021-10-01
Metastatic Colorectal Cancer
2023-506853-39-00
6
2021-05-20
Adynamic bone disorder
2024-519066-49-01
6
2020-11-16
Basal cell carcinoma (non-melanoma skin cancer)
2024-515365-34-00
6
2020-11-01
diabetic acute Charcot foot (Charcot neuroarthropathy)
2024-510579-40-00
9
2020-10-07
Rhabdoyosarcoma
2023-510527-29-00
4
2020-09-01
Cancer
2024-518384-36-00
4
2020-08-31
Idiopathic membranous nephropathy and severe proteinuria
2024-512186-14-00
6
2020-08-24
Fluid overload/fluid accumulation
2023-509847-29-00
7
2020-04-09
Advanced solid tumors
2024-517854-91-00
5
2019-08-05
Metastatic or high-risk recurrent prostate cancer managed with androge
2024-516585-11-00
4
2018-06-12
Advanced melanoma
2024-515413-18-00
4
2017-12-22
Metastatic renal cell carcinoma (mRCC)
2023-506987-15-00
9
2016-11-17
Metastatic Castration-Resistant Prostate Cancer
2024-516078-31-00
10
2015-05-05
Recurrent and Primary Refractory Ewing Sarcoma
2025-521067-13-00
5
2026-04-24
Atherosclerotic Cardiovascular Disease (ASCVD)
2025-521510-25-00
4
2026-01-13
Acne vulgaris
2025-522598-12-00
10
2025-12-17
Untreated Metastatic Pancreatic Ductal Adenocarcinoma
2025-520520-17-00
5
2025-09-05
Heterozygous familial hypercholesterolaemia
2024-515524-36-00
5
2025-05-30
Chronic Weight Management
2024-513307-13-00
4
2025-05-26
Advanced/metastatic solid tumors including gynecological
cancers (endo
2023-506434-69-00
4
2025-02-11
Chronic Kidney Disease
2023-509662-38-00
4
2025-01-22
Type 2 diabetes and painful diabetic peripheral neuropathy
2024-517264-27-00
4
2024-12-13
Knee osteoarthritis
Showing 145–168 of 293 trials